Liver cirrhosis in Iceland and Sweden: Incidence, aetiology and outcomes

Scandinavian Journal of Gastroenterology

Volumn 44, Issue 8, 2009, Pages 984-993

  Gunnarsdottir, Steingerdur Anna ^a   Olsson, Rolf ^a   Ólafsson, Sigurdur ^b   Cariglia, Nick ^c   Westin, Johan ^a   Thjódleifsson, Bjarni ^b   Björnsson, Einar ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^c Akureyri District Hospital   (Iceland)

Author keywords

Aetiology; Alcoholic liver disease; Liver cirrhosis; Mortality; Natural history; Prognosis; Survival

Indexed keywords

ADULT; ALCOHOL CONSUMPTION; ALCOHOL LIVER CIRRHOSIS; ARTICLE; CONTROLLED STUDY; FEMALE; HEMOCHROMATOSIS; HEPATITIS B; HEPATITIS C VIRUS; HUMAN; ICELAND; INCIDENCE; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATIENT IDENTIFICATION; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SCORING SYSTEM; SURVIVAL; SWEDEN;

AGED; FEMALE; HUMANS; ICELAND; INCIDENCE; LIVER CIRRHOSIS; LIVER CIRRHOSIS, ALCOHOLIC; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SWEDEN;

EID: 70350639743     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.1080/00365520902912571     Document Type: Article

References (52)

1. Orrego H, Israel Y, Blendis LM. Alcoholic liver disease: Information in search of knowledge? Hepatology 1981;/1:/ 267-83.
2. Lelbach WK. Cirrhosis in the alcoholic and its relation to the volume of alcohol abuse. Ann NY Acad Sci 1975;/252:/ 85-105.
3. Becker U, Deis A, Sorensen TI, Gronbaek M, Borch- Johnsen K, Muller CF, et al. Prediction of risk of liver disease by alcohol intake, sex, and age: A prospective population study. Hepatology 1996;/23:/1025-9.
4. Arria AM, Tarter RE, Van Thiel DH. Vulnerability to alcoholic liver disease. Recent Dev Alcohol 1991;/9:/185-204.
5. Jarvelainen HA, Orpana A, Perola M, Savolainen VT, Karhunen PJ, Lindros KO. Promoter polymorphism of the CD14 endotoxin receptor gene as a risk factor for alcoholic liver disease. Hepatology 2001;/33:/1148-53.
6. Monzoni A, Masutti F, Saccoccio G, Bellentani S, Tiribelli C, Giacca M. Genetic determinants of ethanol-induced liver damage. Mol Med 2001;/7:/255-62.
7. Pares A, Barrera JM, Caballeria J, Ercilla G, Bruguera M, Caballeria L, et al. Hepatitis C virus antibodies in chronic alcoholic patients: Association with severity of liver injury. Hepatology 1990;/12:/1295-9.
8. Naveau S, Giraud V, Borotto E, Aubert A, Capron F, Chaput JC. Excess weight risk factor for alcoholic liver disease. Hepatology 1997;/25:/108-11.
9. Savolainen VT, Liesto K, Mannikko A, Penttila A, Karhunen PJ. Alcohol consumption and alcoholic liver disease: evidence of a threshold level of effects of ethanol. Alcohol Clin Exp Res 1993;/17:/1112-7.
10. Sorensen TI. Alcohol and liver injury: dose-related or permissive effect? Liver 1989;/9(4):/189-97.
11. Sorensen TI, Orholm M, Bentsen KD, Hoybye G, Eghoje K, Christoffersen P. Prospective evaluation of alcohol abuse and alcoholic liver injury in men as predictors of development of cirrhosis. Lancet 1984;/2(8397):/241-4.
12. Norstrom T, Ramstedt M. Mortality and population drinking: A review of the literature. Drug Alcohol Rev 2005;/24:/ 537-47.
13. Ramstedt M. Per capita alcohol consumption and liver cirrhosis mortality in 14 European countries. Addiction 2001;/96 Suppl 1:/S19-33.
14. Rossow IMP, .ö sterberg E. Explanations and implications of concurrent and diverging trends. Alcohol consumption and alcohol-related harm in the Nordic countries in 1990-2005. Nordic Stud Alcohol Drugs 2007;/24:/85-95.
15. Ramstedt M. Population drinking and liver cirrhosis mortality: Is there a link in Eastern Europe? Addiction 2007;/102:/ 1212-23.
16. Mann RE, Smart RG, Anglin L, Rush BR. Are decreases in liver cirrhosis rates a result of increased treatment for alcoholism? Br J Addict 1988;/83:/683-8.
17. Mann RE, Smart RG, Rush BR, Zalcman RF, Suurvali H. Cirrhosis mortality in Ontario: effects of alcohol consumption and Alcoholics Anonymous participation. Addiction 2005;/100:/1669-79.
18. Holder HD, Parker RN. Effect of alcoholism treatment on cirrhosis mortality: A 20-year multivariate time series analysis. Br J Addict 1992;/87:/1263-74.
19. D'Amico G, Morabito A, Pagliaro L, Marubini E. Survival and prognostic indicators in compensated and decompensated cirrhosis. Dig Dis Sci 1986;/31:/468-75.
20. Gines P, Quintero E, Arroyo V, Teres J, Bruguera M, Rimola A, et al. Compensated cirrhosis: natural history and prognostic factors. Hepatology 1987;/7:/122-8.
21. Gual A, Colom J. Why has alcohol consumption declined in countries of southern Europe? Addiction 1997;/92 Suppl 1:/ S21-31.
22. Ludviksdottir D, Skulason H, Jakobsson F, Thorisdottir A, Cariglia N, Magnusson B, et al. Epidemiology of liver cirrhosis morbidity and mortality in Iceland. Eur J Gastroenterol Hepatol 1997;/9:/61-6.
23. Lehmann EL. Testing statistical hypotheses. New York: Wiley; 1959. pp 140-3.
24. Statens Folkhälsoinstitut. Swedish National Institute of Public Health (SNIPH). Available at: http://www.fhi.se/ statistik Fö rsäljningsstatistik fö r alkoholdrycker, p. 13.
25. The National Statistical Institute of Iceland (Hagstofa Islands). Available at: http://www.statice.is price and consumption: Sales of alcohol 1980-2005.
26. Bosetti C, Levi F, Lucchini F, Zatonski WA, Negri E, La Vecchia C. Worldwide mortality from cirrhosis: An update to 2002. J Hepatol 2007;/46:/827-39.
27. www.can.se Drogutveckling i Sverige. Rapport 98. 2006.
28. Thjodleifsson B. Á fengisneysla Íslendinga og áhrif hennar á heilsufar. Manneldismál 1980;/2:/51-5.
29. Gudmundsdottir A. Ikke-registrerad alcoholconsumption pa° Island. Alcoholpolitik- Tidskrift fö r nordisk alcoholforskning 1990;/7:/155-64.
30. Bataller R, North KE, Brenner DA. Genetic polymorphisms and the progression of liver fibrosis: A critical appraisal. Hepatology 2003;/37:/493-503.
31. Helgason A, Sigurdardottir S, Nicholson J, Sykes B, Hill EW, Bradley DG, et al. Estimating Scandinavian and Gaelic ancestry in the male settlers of Iceland. Am J Hum Genet 2000;/67:/697-717.
32. Kuo P, Neale MC, Riley BP, Webb BT, Sullivan PF, Vittum J, et al. Identification of susceptibility loci for alcohol-related traits in the Irish Affected Sib Pair Study of Alcohol Dependence. Alcohol Clin Exp Res 2006;/30:/1807-16.
33. Utsunomiya T, Okamoto M, Wakiyama S, Hashimoto M, Fukuzawa K, Ezaki T, et al. A specific gene-expression signature quantifies the degree of hepatic fibrosis in patients with chronic liver disease. World J Gastroenterol 2007; 21;13:383-90.
34. Ramstedt M. Alcohol-related mortality in 15 European countries in the postwar period. Eur J Popul 2002;/18:/ 307-23.
35. Olafsdottir H. Trends in alcohol consumption and alcoholrelated harm in Iceland. Nord Stud Alcohol Drugs 2007;/24 Suppl:/47-60.
36. www.sos.se Insatser och klienter i behandlingsenheter inom misbrukarva°rden den 1 april 2003.
37. Bergmark K. The Links and Alcoholics Anonymous: Two AA movements in Sweden. In: Eisenbach-Stangl I, Rosenquist P, editors. Diversity in unity studies of Alcoholics Anonymous in eight societies 1998;NAD Publication (33):83.
38. Kurube N. Självhjälp och överlevnad. En studie av Länkarana. Stockholm. Stockholms universitet Institutionen fö r social arbete - Socialhögskolan. 1997.
39. Smart RG, Mann RE. The impact of programs for high-risk drinkers on population levels of alcohol problems. Addiction 2000;/95:/37-51.
40. Olafsdottir H. The dynamics of shifts in alcoholic beverage preference: effects of the legalization of beer in Iceland. J Stud Alcohol 1998;/59:/107-14.
41. Brand DA, Saisana M, Rynn LA, Pennoni F, Lowenfels AB. Comparative analysis of alcohol control policies in 30 countries. PLoS Med 2007;/4:/e151.
42. Welfare SNBoHa. The cause of death register. Statistik efter ämne, dödsorsaker. Available at: http://wwwsosse. 2003:64, 68. Table 1A, B.
43. Islands H. Population, births and deaths, deaths by sex, age and cause of death 1981-2004 and mid-year population by sex and age 1841-2006. Available at: http://wwwstaticeis.
44. Stokkeland K, Brandt L, Ekbom A, Osby U, Hultcrantz R. Morbidity and mortality in liver diseases in Sweden 1969- 2001 in relation to alcohol consumption. Scand J Gastroenterol 2006;/41:/459-64.
45. Ramstedt M. Has the impact of population drinking on harm become weaker in Sweden? An analysis of the development in alcohol consumption and alcohol-related harm in Sweden 1990-2005. Nord Stud Alcohol Drugs 2007;/24 Suppl:/73-83.
46. Romelsjo A. Can an improvement and increase in treatment explain unexpected trends in alcohol-related harm in Sweden? Addiction 2007;/102:/669-71.
47. Carbonell N, Pauwels A, Serfaty L, Fourdan O, Levy VG, Poupon R. Improved survival after variceal bleeding in patients with cirrhosis over the past two decades. Hepatology 2004;/40:/652-9.
48. Gunnarsdottir SA, Olsson R, Bjornsson ES. Characteristics, prognosis and outcome of patients with oesophageal varices in a university hospital in Sweden 1994-1999. Scand J Gastroenterol 2005;/40:/1462-8.
49. Stokkeland K, Brandt L, Ekbom A, Hultcrantz R. Improved prognosis for patients hospitalized with esophageal varices in Sweden 1969-2002. Hepatology 2006;/43:/500-5.
50. D'Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies. J Hepatol 2006;/44:/217-31.
51. Propst A, Propst T, Zangerl G, Ofner D, Judmaier G, Vogel W. Prognosis and life expectancy in chronic liver disease. Dig Dis Sci 1995;/40:/1805-15.
52. Haukeland JW, Lorgren I, Schreiner LT, Frigstad SO, Brandsaeter B, Bjoro K, et al. Incidence rates and causes of cirrhosis in a Norwegian population. Scand J Gastroenterol 2007;/42:/1501-8.